Centene Corp., US15133V1035

Centene Stock - Weekly review and managed care sector check

Published on 06/20/2026 at 19:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Centene stock ends a busy week for US managed care names, with investors weighing cost-cutting measures, enrollment trends and valuation debates against a still-solid Standard & Poor's 500 index backdrop.

Centene Corp., US15133V1035, Illustration mit AI erstellt.
Centene Corp., US15133V1035, Illustration mit AI erstellt.

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/20/2026, 19:13 ET. Details in the imprint.

Centene Corp. (US15133V1035) closes out the week as investors digest cost-cutting efforts, enrollment headwinds and broader managed care moves. The stock remains part of a sector that has lagged the Standard & Poor's 500 index this year, prompting renewed valuation scrutiny.

Go deeper

All news and background on Centene stock

Track Centene's latest cost initiatives, regulatory developments and earnings trends alongside historical price data and peer comparisons.

How Centene fits this week

Centene is one of the larger US managed care players focused on government-sponsored health programs, including Medicaid, Medicare Advantage and Marketplace plans. The company's profile data on Yahoo Finance highlights its concentration in these lines of business.

During the week, investors continued to weigh earlier cost actions, including voluntary employee buyout programs, against lingering enrollment pressure after Medicaid redeterminations reduced membership in government-backed plans. A recent Reuters piece on Medicaid redeterminations underscored the broader industry impact of this process on managed care margins.

Peer-group moves and sector context

The managed care group, including names such as UnitedHealth, Elevance Health and Molina Healthcare, has traded with more volatility than the wider S&P 500 this year as reimbursement debates and utilization trends stayed in focus. MarketWatch data on CNC show how Centene shares have moved within that backdrop.

Against this backdrop, Centene's valuation continues to be compared with peers on earnings multiples and medical loss ratios, while investors also watch for any fresh commentary on 2025 profitability targets and capital allocation plans.

How the company makes money

Centene generates most of its revenue by managing health benefits for government-sponsored programs, especially Medicaid managed care and Medicare Advantage, and by offering Marketplace plans and related specialty services such as pharmacy benefit management.

Where the stock trades today

The shares of Centene Corp. (US15133V1035) trade on the New York Stock Exchange at around $61 per share as of 06/20/2026, 15:59 ET.

Centene at a glance

  • Company: Centene Corporation
  • ISIN: US15133V1035
  • WKN: 889714
  • Ticker: CNC
  • Venue: NYSE
  • Price (as of 06/20/2026, 15:59 ET): 61.00 USD
  • Market cap: approximately 33,000,000,000 USD (as of 06/20/2026)
  • Sector / Industry: Health Care / Managed Care
  • Index membership: Standard & Poor's 500 index
  • Next earnings date: not officially scheduled

More on Centene stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US15133V1035 | CENTENE CORP. | boerse | 69592161 | bgmi